Bladder CancerBladder Cancer Staging |
Physician-developed and -monitored. Original Date of Publication: 15 Jun 1998
|
|
Original Source: http://www.urologychannel.com/bladdercancer/staging.shtml | |
|
Home » Bladder Cancer » Bladder Cancer Staging | 
 |
Bladder Cancer Staging
Once the physician has determined that a tumor exists, the next step is to clarify the tumor's status. Several questions will have to be answered: Is the tumor large or small? Does it lie within the lining of the bladder or has it extended into the surrounding tissue? Has the tumor spread to nearby lymph nodes? Has the tumor metastasized to distant sites within the body?
Fortunately, a number of systems have been developed to answer these questions. The most common of these — the TNM (tumor, node, metastasis) system — allows tumors to be classified, or "staged," according to their overall characteristics. A biopsy is removed and sent to a histopathologist for examination under a microscope. The pathologist then assigns a stage and a grade to the tissue sample.
The stage refers to the physical location of the tumor within the bladder or, more specifically, the tumor's depth of penetration. In general, tumor stage is confined to one of two categories: (1) superficial, surface tumors, or (2) invasive, deep-spreading tumors. Superficial tumors affect only the bladder lining. They grow up and out from the lining tissue and extend into the bladder's hollow cavity. Invasive tumors grow down into the deeper layers of bladder tissue, and they may involve surrounding muscle, fat, and/or nearby organs. Invasive tumors are more dangerous than superficial tumors, since they are more likely to metastasize.
The grade is an estimate of the speed of tumor growth as suggested by cell features seen under a microscope. Most systems are based upon the degree of tumor cell anaplasia - that is, the loss of cellular "differentiation," the distinguishing characteristics of a cell. The World Health Organization (WHO) grading system groups transitional cell carcinomas (TCCs) into three grades that correspond to well-, moderately, and poorly differentiated cells. The International Union Against Cancer (UICC) has devised a four-grade system that considers Grade 1 tumors to be well-differentiated, Grade 2 to be moderately differentiated, and Grades 3 or 4 to be poorly differentiated. Both systems are widely used and can be summarized as follows:
- Grade 1 (well-differentiated)
- Grade 2 (moderately differentiated)
- Grade 3 or Grade 4 (poorly differentiated)
There is a continuing debate about the classification of benign bladder lesions known as papillomas. The WHO defines papilloma as a single papillary (wart-like) growth with 8 or less cell layers in normal-looking surface tissue. By contrast, many pathologists and urologists classify papilloma as a Grade 1 TCC because of its tendency to recur and not to invade muscle.
There is a strong correlation between tumor stage and tumor grade. Nearly all superficial tumors are low grade; that is, they are Grade 1 tumors, with cells that are distinctly specialized and well-differentiated, whereas nearly all muscle-invasive tumors are high grade; that is, they are Grade 3 or 4 tumors, with cells that are nonspecialized and poorly differentiated. More importantly, there is a strong correlation between tumor stage and prognosis (the probable outcome of a disease), with superficial tumors having the most chance of a favorable result.
The latest TNM system for staging bladder cancer was developed by the UICC in 1997 (see Table 2).
Table 2: TNM Classification of Urinary Bladder Cancer
| T - Tumor | N - Regional Lymph Nodes | M - Distant Metastasis |
|---|---|---|
|
TX - Primary tumor cannot be evaluated
T0 - No primary tumor Ta - Noninvasive papillary carcinoma TIS - Carcinoma in situ ("flat tumor") T1 - Tumor invades connective tissue under the epithelium (surface layer) T2 - Tumor invades muscle
T2b - Deep muscle affected (outer half)
T3b - macroscopically (e.g., visible tumor mass on the outer bladder tissue) |
NX - Regional lymph nodes cannot be evaluated N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node < 2 cm in size N2 - Metastasis in a single lymph node > 2 cm, but < 5 cm in size, or Multiple lymph nodes < 5 cm in size N3 - Metastasis in a lymph node > 5 cm in size |
MX - Distant metastasis cannot be evaluated M0 - No distant metastasis M1 - Distant metastasis |
Bladder Cancer, Bladder Cancer Staging reprinted with permission from urologychannel.com
© 1998-2009 Healthcommunities.com, Inc. All Rights Reserved.
Bladder Cancer (continued...)
Bladder Cancer Resources
 | Questions to Ask Your Doctor About Your Cancer
The more knowledge you have, the easier it is to make decisions about your cancer treatment. Print this free handout to take with you on your next office visit. |
|
|
 | Join Our Bladder Cancer Forum
Do you have a question, want to share medical advice, or just need to discuss your situation with someone else having a similar experience? The healthchannels forum is a resource for everyone to share and discuss their health and medical needs with others. |
||
 | Living with...Share your story
Do you have a personal health story that you would like to share with others? As a source of free patient education, our goal is to provide our users with trustworthy information and support from others. That's why we've started our "Living with..." sections. | ||
|
Our "Living With..." support pages are a place to share experiences about living with a certain condition, disease, disorder, or illness and for loved ones of those dealing with health-related issues. Many people, especially when newly diagnosed, find comfort in knowing that others are having a similar experience. National Cancer Survivors Day is June 7, 2009
| |||
To quickly access health information from your website's browser,
| |||
email this
